Equities

Malaysian Genomics Resource Centre Bhd

MGRC:KLS

Malaysian Genomics Resource Centre Bhd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (MYR)0.395
  • Today's Change-0.005 / -1.25%
  • Shares traded131.10k
  • 1 Year change-12.22%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Malaysian Genomics Resource Centre Berhad is a Malaysia-based genomics and biopharmaceutical company. The Company is engaged in enabling personalized and precision medicine through genetics, genomics, immunotherapy and biopharmaceutical services, as well as investment holding. Its services include Genome Sequencing Services, Genome Analysis Services, Genetic Screening Services and Cancer Immunotherapy. Its whole genome sequencing (WGS) is a comprehensive technique used to determine the complete DNA sequence of an individual’s entire genome. Its flagship product, the Dtect genetic screening tests, inspects an individual’s DNA for markers associated with genetic variations that influence various biological processes. Its CAR T-cell immunotherapy provides a highly targeted approach to bolster the immune system’s ability to detect and eliminate cancer cells. Its Genome analysis includes services, such as bioinformatics, trait analysis, and trio sequencing.

  • Revenue in MYR (TTM)8.50m
  • Net income in MYR-19.71m
  • Incorporated2004
  • Employees19.00
  • Location
    Malaysian Genomics Resource Centre Bhd8F Jalan Teknologi 3/6, Taman Sains SelaPETALING JAYA 47810MalaysiaMYS
  • Phone+60 378900015
  • Fax+60 361503232
  • Websitehttp://www.mgrc.com.my/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Smile-Link Healthcare Global Bhd35.35m91.00k40.36m--444.441.209.051.140.00040.00040.14110.13340.69143.333.32--0.2682.670.36673.2650.9949.510.38763.981.101.190.2657--11.406.57180.20-23.02-5.19--
Hong Seng Consolidated Bhd15.74m-76.93m51.08m22.00--0.1709--3.24-0.015-0.0150.00310.05850.04173.000.1312---22.54---24.09---162.35---540.99--6.02-25.400.077--------------
MALAYSIAN GENOMICS RESOURCE CENTRE BHD8.50m-19.71m54.20m19.00--2.59--6.38-0.1446-0.14460.06160.15260.25455.110.4238---64.46---70.32--56.88---253.29--5.58-180.910.0837--------------
Country Heights Holdings Bhd51.95m-113.08m83.44m325.00--0.1351--1.61-0.3917-0.39170.17552.070.0470.10421.38---10.05-4.51-12.37-5.5465.9465.97-213.83-87.790.2548-22.360.0759--10.03-10.87-31.30---22.16--
LYC Healthcare Bhd128.52m-19.68m85.79m----2.15--0.6676-0.0301-0.03010.19690.05580.56486.806.36---6.71-7.65-12.42-10.7952.2947.98-11.88-17.300.4718-0.07980.6124--39.2676.03-2.55--21.04--
TOPVISION Eye Specialist Bhd42.96m4.72m199.31m57.00----22.254.640.01850.01850.16810.1150.877511.2133.76--9.858.7611.149.9549.3549.9111.2311.242.5112.070.357346.968.8818.1811.5229.5952.87--
Cengild Medical Bhd66.48m11.80m249.87m--21.142.2416.653.760.01420.01420.080.1340.50919.8510.65--9.0410.9610.0413.1346.1742.8517.7514.357.9317.610.1127--9.0643.1841.50---13.85--
Data as of Jul 26 2024. Currency figures normalised to Malaysian Genomics Resource Centre Bhd's reporting currency: Malaysian Ringgit MYR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.